Best Telehealth Clinics in Hawaii (2026)

Hawaii has one of the most restrictive telehealth controlled substance prescribing environments in the country. Under HRS Chapter 453 (medical practice) and HRS § 329-38 (controlled substance prescriptions), all providers prescribing controlled substances via telehealth must be physically located in Hawaii at the time of the encounter. This is a prescriber-location requirement, not a patient-location requirement — and it is the primary reason most mainland telehealth platforms cannot serve Hawaii for controlled substances.

An in-person consultation is required before prescribing opiates or certifying medical cannabis via telehealth. HB 951 permits a limited 3-day opiate supply via telehealth if the patient was previously evaluated in-person by another provider in the same medical group. Testosterone is not an opiate and is not subject to the opiate-specific in-person requirement, but the prescriber-location restriction still applies.

Hawaii has IMLC membership, but with a significant limitation: Hawaii cannot serve as a State of Principal Licensure (SPL). Physicians can get a Hawaii license through the IMLC, but they must still be physically in Hawaii to prescribe controlled substances. This renders the IMLC benefit largely theoretical for controlled substance telehealth.

Hawaii is a full practice authority state for nurse practitioners. NPs can prescribe independently, but they are still subject to the Hawaii prescriber-location requirement for controlled substances.

Hawaii Medicaid does not cover GLP-1 receptor agonists for obesity. GLP-1s are not controlled substances and are not affected by the prescriber-location restriction — mainland telehealth platforms can prescribe GLP-1s to Hawaii patients.

Hawaii has the highest top income tax bracket in the country at 11% (for income over $325,000 single). The state uses a general excise tax (GET) rather than a traditional sales tax. Prescription drugs are exempt from the GET.

Hawaii has 1.5 million residents spread across multiple islands. Provider availability for controlled substance telehealth is among the lowest in the country due to the prescriber-location requirement.

TRT Nation explicitly excludes Hawaii. Enhance MD also excludes Hawaii. All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) technically list Hawaii, but they must have providers physically located in the state — verify before enrolling. The geographic isolation of Hawaii makes it expensive for telehealth platforms to maintain local providers.

GLP-1 availability is unrestricted since GLP-1s are not controlled substances. The prescriber-location restriction does not apply. All national GLP-1 providers serve Hawaii. No Medicaid GLP-1 obesity coverage.

HRT, hair loss, and ED providers serve Hawaii for non-controlled medications. Controlled substance prescriptions face the same prescriber-location barrier as TRT.

TRT pricing from providers that may serve Hawaii: Maximus $100/mo ($1,300/year), Hone Health $25/mo entry. TRT Nation ($99/mo) does not serve Hawaii. The limited provider pool may result in fewer budget options. Verify availability before enrolling.

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Hawaii Medicaid does not cover GLP-1s for obesity.

Prescription drugs are exempt from Hawaii's general excise tax. Hawaii has the highest top income tax rate in the country at 11%. The state has a very high cost of living, particularly for housing and groceries.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo (for non-controlled ED medications).

TRT (testosterone replacement therapy)

Hawaii requires controlled substance prescribers to be physically located in Hawaii (HRS § 329-38). This eliminates most mainland telehealth platforms. TRT Nation and Enhance MD exclude the state. Providers claiming "all 50 states" must have Hawaii-based prescribers. Both compounded and FDA-approved testosterone are theoretically available but provider access is severely limited.

GLP-1 weight loss

No state-specific GLP-1 restrictions. The prescriber-location requirement does not apply to non-controlled substances. Federal FDA compounding rules apply. No Medicaid obesity coverage.

HRT (hormone replacement therapy)

Non-controlled HRT medications are not subject to the prescriber-location requirement. Standard federal rules apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules. No additional state restrictions for non-controlled medications.

ED (erectile dysfunction)

Non-controlled ED medications follow standard federal rules. Controlled ED medications would be subject to the prescriber-location requirement.

Peptides

Controlled peptides are subject to the prescriber-location requirement. Non-controlled peptides follow standard federal rules.